Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Transplant Cell Ther. 2021 May 21;27(8):689–695. doi: 10.1016/j.jtct.2021.05.007

Table IV.

Multivariate analysis of factors for progression-free and overall survival after second HCT.

Variables Progression Free Survival Overall Survival
HR 95% CI p value HR 95% CI p value
History of cGVHD after first HCT 3.4 1.8–6.4 <0.001 2.9 1.5–5.7 0.001
HCT-CI≥2 2.1 1.2–3.7 0.01 2.6 1.4–4.9 0.003
≤6 months remission after first HCT 1.2 0.7–2.2 0.4 2.6* 1.1–5.8 0.02
Second HCT before 2011 1.2 0.7–1.9 0.5 2.4* 1.1–5.1 0.02

Abbreviations: HCT=hematopoietic cell transplantation; HR=hazards ratio; CI=confidence interval; cGVHD=chronic graft-versus-host disease; HCT-CI=hematopoietic cell transplantation comorbidity index; NS=not significant.

*

Hazard ratios reflect adjustment for a significant interaction effect between transplant decade and duration of remission of first transplant.